B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ci 1040

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ci 1040, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

avutometinib
3 shared targets
tak
2 shared targets
binimetinib
2 shared targets
cobimetinib
2 shared targets
mirdametinib
2 shared targets
trametinib
2 shared targets · score 45.1
naporafenib
2 shared targets
selumetinib
2 shared targets
orantinib
4 shared targets
cep
4 shared targets
Loading evidence profile...

This evidence profile for Ci 1040 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.